CClinicalTrials.gg
RecruitingNCT03209674RIPOSTEUpdated Apr 3, 2026

Registry for the Improvement of Postoperative OutcomeS in Cardiac and Thoracic surgEry

An observational study in Heart Diseases, Death and Postoperative Complications, sponsored by CMC Ambroise Paré. Recruiting at 1 site in France. Per ClinicalTrials.gov, last updated 2026-04-03.

Sponsored by CMC Ambroise Paré · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
8,000
Sex
All
01

Study summary

The registry for the improvement of postoperative outcomes in cardiac and thoracic surgery aims to prospectively collect data in order to test the association between various preoperative and per-operative variables ; and several postoperative outcomes such as mortality, shock, redo surgery, sepsis and extracorporeal life-support.

Read the detailed description

Cardiac and thoracic surgery is plagued by severe morbidity and mortality. Understanding and being able to predict postoperative outcomes may allow to better fit peri-operative care of cardio-thoracic patients.

RIPOSTE database aims to prospectively collect baseline characteristics and per-operative information in order to test associations with the incidence of postoperative outcomes.

Baseline characteristics include: age, EuroSCORE 2 and its components (age, gender, New York Heart Association (NYHA) functional class, angina symptoms, insulin-dependent diabetes mellitus, extracardiac arteriopathy, chronic pulmonary dysfunction, neurological or musculoskeletal dysfunction severely affecting mobility, previous cardiac surgery, renal function with creatinin clearance, active endocarditis, critical preoperative state, left ventricle ejection fraction, recent myocardial infarction, pulmonary artery systolic pressure, procedure urgency and weight of the procedure (coronary artery bypass graft, valve surgery and/or thoracic aorta)) weight, height, preoperative biology and preoperative echocardiography parameters when measured.

Peroperative information include: cardiac bypass duration, type of procedure, implanted device, valve size.

Postoperative outcomes include: death, postoperative shock, mediastinitis, length of stay in intensive care unit, overall length of stay, blood transfusion.

02

Conditions studied

  • Heart Diseases
  • Death
  • Postoperative Complications
  • Cardiac Complication

Keywords

  • Cardiac surgery
  • Thoracic surgery
03

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

All patients undergoing cardiac or thoracic surgery in CMC Ambroise Paré

Inclusion criteria

  • all patients eligible for cardiac or thoracic surgery

Exclusion criteria

Exclusion Criteria:

  • non applicable
04

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
8,000 participants (estimated)
Target follow-up
2 Months
Patient registry
Yes

Interventions

  • ProcedureCardiothoracic surgery

    Cardiac or thoracic procedure

05

What researchers measure

Primary outcomes

  1. In-hospital mortality

    death occurring in the same hospital where the operation took place before discharge from the hospital

    Time frame: During follow-up, until discharge from hospital, up to 1 year.

Secondary outcomes

  1. Postoperative shock

    Use of catecholamines (dobutamine, norepinephrine and/or epinephrine) in order to achieve adequate cardiac output (cardiac index \> 2.2 l/min/m2), in the first 24 hours after surgery

    Time frame: In the first 24 hours after surgery

  2. Length of stay in the ICU (days)

    length of stay in the intensive care unit after cardiac or thoracic surgery

    Time frame: During follow-up, until discharge from the ICU, up to 1 year.

  3. Total length of stay (days)

    length of stay in the hospital, including preoperative period

    Time frame: During follow-up, until discharge from the hospital, up to 1 year.

  4. Mediastinitis

    Incidence of mediastinitis in the postoperative period

    Time frame: During follow-up, until discharge from the hospital, up to 1 year.

  5. Redo surgery

    Redo surgery after primary surgery

    Time frame: During follow-up, until discharge from the hospital, up to 1 year.

  6. Pneumoniae

    Hospital-acquired or Ventilator-acquired pneumonia as defined by Center for Disease Control guidelines

    Time frame: During follow-up, until discharge from the hospital, up to 1 year.

06

Study locations

1 of 1 sites recruiting
07

References and documents

Publications

  • Suc G, Estagnasie P, Brusset A, Procopi N, Squara P, Nguyen LS. Effect of BNP on risk assessment in cardiac surgery patients, in addition to EuroScore II. Sci Rep. 2020 Jul 2;10(1):10865. doi: 10.1038/s41598-020-67607-0. PubMed 32616802 ↗

Individual participant data

Plan to share: No — non-applicable.

08

Registry details

Key details

Study ID
NCT03209674
Lead sponsor
CMC Ambroise Paré
Responsible party
Sponsor
First posted
Jul 6, 2017
Start date
Jan 1, 2012
Primary completion
Dec 31, 2030 (estimated)
Completion
Dec 31, 2030 (estimated)
Last update
Apr 3, 2026

Study contacts

Alain Brusset, MD
Contact
brusseta@club-internet.fr
Lee S Nguyen, MD
Contact
nguyen.lee@icloud.com
Marie-Caroline Merand
study chair · CMC Ambroise Paré

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion